End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
159,500 KRW | +4.32% | +5.21% | -33.82% |
May. 16 | Medy-Tox Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 21 | Medy-Tox Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 728
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100.0
%
| 191,465 | 100.0 % | 217,160 | 100.0 % | +13.42% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
36.8
%
| 66,704 | 34.8 % | 79,821 | 36.8 % | +19.66% |
Asia
33.9
%
| 69,179 | 36.1 % | 73,714 | 33.9 % | +6.56% |
America
22.2
%
| 43,633 | 22.8 % | 48,297 | 22.2 % | +10.69% |
Middle East
3.9
%
| 4,929 | 2.6 % | 8,536 | 3.9 % | +73.19% |
Europe
3.0
%
| 6,555 | 3.4 % | 6,565 | 3.0 % | +0.15% |
Other
0.1
%
| - | - | 227 | 0.1 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hyun-Ho Jeong
CEO | Chief Executive Officer | 61 | 00-05-01 |
Gi-Hyuk Yang
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
Hee-Seok Joo
BRD | Director/Board Member | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hyun-Ho Jeong
CEO | Chief Executive Officer | 61 | 00-05-01 |
Gi-Hyuk Yang
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
Hee-Seok Joo
BRD | Director/Board Member | - | - |
Dong-Hyeon Yoo
BRD | Director/Board Member | 63 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 440,635 | 0 | 0 | 71.68 % |
Stock B | 1 | 7,298,497 | 5,231,328 ( 71.68 %) | 567,172 ( 7.771 %) | |
Stock C | 0 | 21 | 0 | 21 ( 100.00 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
MEDY-TOX INC. 7.80% | 569,340 | 7.80% | 62,662,557 $ |
Company contact information
Sector
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.82% | 781M | |
+6.96% | 101B | |
+8.29% | 42.63B | |
-11.09% | 33.5B | |
+82.32% | 29.77B | |
-11.82% | 16.14B | |
+1.39% | 14.31B | |
-12.13% | 11.55B | |
+176.65% | 10.53B | |
+6.74% | 9.2B |
- Stock Market
- Equities
- A086900 Stock
- Company Medy-Tox Inc.